CNBX Pharmaceuticals Inc. (CNBX) › Shareholders' EquityCNBX Pharmaceuticals Inc. (CNBX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2005: -$1.3K2006: $144.4K2007: $317.3K2008: $289.9K2009: $174.9K2010: $60.0K2011: -$47.3K2012: -$49.0K2013: -$105.4K2014: $40.1K2015: -$309.6K2016: -$467.4K2017: -$2.94M2018: $2.65M2019: $14.74M2020: $1.76M2021: $1.81M2022: $1.63M2023: -$2.02M2024: -$2.48M2025: -$2.50M-$2.50M2005Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025-$2.50M-0.7%2024-$2.48M-22.9%2023-$2.02M-223.6%2022$1.63M-9.6%2021$1.81M+2.3%2020$1.76M-88.0%2019$14.74M+457.3%2018$2.65M+190.0%2017-$2.94M-528.7%2016-$467.4K-51.0%2015-$309.6K-872.5%2014$40.1K+138.0%2013-$105.4K-115.1%2012-$49.0K-3.5%2011-$47.3K-178.9%2010$60.0K-65.7%2009$174.9K-39.6%2008$289.9K-8.7%2007$317.3K+119.7%2006$144.4K+11394.0%2005-$1.3K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share